Skip to content

Xia Zhang

3 papers in the library · 4 citations · publishing 2005-2019

Papers

Sort Most recent Most cited

Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside

Depressive Disorders: Mechanisms, Measurement and Management 2019 Min Cai, Huaning Wang, Xia Zhang 4 citations

Numerous antidepressants are available for the treatment of the major depressive disorder (MDD). Unfortunately, the disadvantages of these antidepressive medications, including inadequate treatment response, the therapeutic lag between drug administration and the onset of symptoms alleviation, and the safety consideration limit their clinical use and accelerate the exploration of advanced...

DOI: 10.1007/978-981-32-9271-0_15 (opens in new tab) Full text (opens in new tab) Ketamine Novel pharmacological antidepressants Neurotransmitters Anti-inflammation

Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice.

Behavioural Brain Research May 1, 2015 Renee Kinden, Xia Zhang

Anxiety disorders are one of the most prevalent classes of mental disorders affecting the general population, but current treatment strategies are restricted by their limited efficacy and side effect profiles. Although the cannabinoid system is speculated to be a key player in the modulation of stress responses and emotionality, the vast majority of current research initiatives had not...

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.

Journal of Clinical Investigation November 1, 2005 Wen Jiang, Yun Zhang, Lan Xiao et al.

The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory...